Elusys Therapeutics is a New Jersey biopharma company that develops medical countermeasures against infectious agents. Its filings show it lobbied Congress on health issues, mainly about readiness of the Strategic National Stockpile and legislation like H.R. 2707 (the Protecting American Families and Servicemembers from Anthrax Act). It hired Horizons Global Solutions LLC and reported about $120,000 in lobbying since 2026 filings began.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JULIE LASSETER
The latest disclosures for this client.
HORIZONS GLOBAL SOLUTIONS LLC
Q2HORIZONS GLOBAL SOLUTIONS LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
HORIZONS GLOBAL SOLUTIONS LLC
mr STEPHEN ELLIOTT BOYD
HORIZONS GLOBAL SOLUTIONS LLC
mr DAVID FORREST LASSETER
HORIZONS GLOBAL SOLUTIONS LLC
HORIZONS GLOBAL SOLUTIONS LLC
4AHORIZONS GLOBAL SOLUTIONS LLC
4AHORIZONS GLOBAL SOLUTIONS LLC
Q4HORIZONS GLOBAL SOLUTIONS LLC
Q3HORIZONS GLOBAL SOLUTIONS LLC
Q2HORIZONS GLOBAL SOLUTIONS LLC
Q1